Therapeutic Advances in Endocrinology and Metabolism

Papers
(The H4-Index of Therapeutic Advances in Endocrinology and Metabolism is 17. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review117
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review94
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity57
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults39
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis32
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study28
Controversies in the management of active Charcot neuroarthropathy26
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease22
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach22
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses20
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system20
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers19
Update on genetics and epigenetics in metabolic associated fatty liver disease18
Is there a causal relationship between hypothyroidism and hyponatremia?18
Pheochromocytoma: a changing perspective and current concepts17
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study17
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor17
0.037906885147095